V023-8937 Screening compound: 2-[4-(2-chloropropanoyl)piperazin-1-yl]-6-{[4-(2-methylphenyl)piperazin-1-yl]methyl}-3,4-dihydropyrimidin-4-one

V023-8937 Screening compound: 2-[4-(2-chloropropanoyl)piperazin-1-yl]-6-{[4-(2-methylphenyl)piperazin-1-yl]methyl}-3,4-dihydropyrimidin-4-one
V023-8937 Screening compound: 2-[4-(2-chloropropanoyl)piperazin-1-yl]-6-{[4-(2-methylphenyl)piperazin-1-yl]methyl}-3,4-dihydropyrimidin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound V023-8937
2-[4-(2-chloropropanoyl)piperazin-1-yl]-6-{[4-(2-methylphenyl)piperazin-1-yl]methyl}-3,4-dihydropyrimidin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V023-8937

Molecular Formula

C23H31ClN6O2 (C23 H31 ClN6 O2)

Compound Name

2-[4-(2-chloropropanoyl)piperazin-1-yl]-6-{[4-(2-methylphenyl)piperazin-1-yl]methyl}-3,4-dihydropyrimidin-4-one

IUPAC name

2-[4-(2-chloropropanoyl)piperazin-1-yl]-6-{[4-(2-methylphenyl)piperazin-1-yl]methyl}-34-dihydropyrimidin-4-one

SMILES

CC(C(N(CC1)CCN1C(N1)=NC(CN(CC2)CCN2c2c(C)cccc2)=CC1=O)=O)Cl

InChI

InChI=1S/C23H31ClN6O2/c1-17-5-3-4-6-20(17)28-9-7-27(8-10-28)16-19-15-21(31)26-23(25-19)30-13-11-29(12-14-30)22(32)18(2)24/h3-6,15,18H,7-14,16H2,1-2H3,(H,25,26,31)

InChI Key

UEHPKNYRHOUXQK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19859650

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

458.99

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.117

Distribution Coefficient, logD

-0.090

Water Solubility, LogSw

-2.66

Polar Surface Area

61.782

Acid Dissociation Constant (pKa)

8.87

Base Dissociation Constant (pKb)

8.63

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

52.17

V023-8937 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V023-8937 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V023-8937?
Check Price and Availability of V023-8937, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V023-8937 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V023-8937
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V023-8937
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V023-8937 available by request